Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasm and derivation of a prognostic model: An international multicenter study (ADENO-IPMN study).
James LucocqNejo JosephJake HawkyardBeate HaugkSteve WhiteJonathan LyeDaniel ParkinsonOmar MownahKrishna MenonTakaki FurukawaYuki HiroseNaoki SasahiraYosuke InoueAnubhav MittalJas SamraAmy SheenMichael FeretisAnita BalakrishnanCarlo CeresaBrian DavidsonRupaly PandeBobby DasariKeith RobertsLulu TannoDimitrios KaraviasJack HelliwellAlistair YoungKate MarksQuentin NunesTomas UrbonasMichael SilvaAlex Gordon-WeeksJenifer BarrieDhanny GomezStijn van LaarhovenHossam NawaraJoseph DoyleRicky BhogalEwen HarrisonMarcus RoalsoDebora CipraniSomaiah ArooriBathiya RatnayakeJonathan KoeaGabriele CapursoStefan StättnerRuben BellottiTareq AlsaoudiNeil BhardwajSrujan RajeshFraser JefferySaxon ConnorAndrew CameronNigel JamiesonAnthony GillKjetil SoreideSanjay PandanaboyanaPublished in: Surgery (2024)
A third of patients achieve long-term disease-free survival (>5 years) after pancreatic resection for adenocarcinoma arising from intraductal papillary mucinous neoplasms. The predictive model developed in the current study can be used to estimate the probability of long-term disease-free survival.